Skip to main content
. 2024 Jan 4;30(2):543–551. doi: 10.1038/s41591-023-02703-y

Extended Data Table 4.

Efficacy Data for Part 1 by Dosing Cohort

graphic file with name 41591_2023_2703_Tab4_ESM.jpg

CR, complete response; mOS, median overall survival; mPFS, median progression-free survival; NYR, not yet reached; ORR, overall response rate; PR, partial response; sCR, stringent complete response; VGPR, very good partial response.